1.Clinical study of compound Qianglizhenxian pill on epilepsy
Ming YU ; Ming HUANG ; Qinglin XUE ; Ming FU ; Jiqing LIU ; Yan CHEN ; Yuying LUAN ; Chenglong LI
Chinese Journal of Rehabilitation Theory and Practice 2003;9(12):732-733
Objective To investigate the clinical effect of compound Qianglizhenxian pill on epilepsy. Methods 94 patients with epilepsy were treated with compound Qianglizhenxian pill, and every course lasted three months. After treatment, checking patients' electroencephalogram again, evaluating the clinical effect according to degrees and numbers of attack. Results After 12 months of treatment, 90.43% of patients got an obvious improvement, while 6.38% for better, 3.19% for validity and no invalid. Conclusions There is a great improvement for patients with epilepsy after taking the medicine. The effective control rate is 92.62% with no toxication on blood system, liver and kidney.
2.Reproducibility analysis of quantitative susceptibility mapping of cerebral subcortical nuclei in healthy adults.
Huan XU ; Qinglin MENG ; Wenping FAN ; Xue WANG ; Mengqi LIU ; Zhiye CHEN
Journal of Southern Medical University 2020;40(12):1810-1815
OBJECTIVE:
To investigate the intra- and inter-scanner reproducibility of quantitative susceptibility mapping (QSM) of cerebral subcortical nuclei in healthy adults.
METHODS:
QSM was performed in 21 healthy adults on two different 3.0T MR scanners, and the region of interest (ROI) method was used to measure the magnetic susceptibility value of the left subcortical nuclei (the head of the caudate, putamen, globus pallidus, thalamus, substantia nigra and red nucleus). The intraclass correlation coefficient (ICC) and Bland-Altman method were used to evaluate the inter-scanner and intra-scanner reliability.
RESULTS:
The ICCs of the susceptibility value ranged from 0.90 to 0.99 for all the subcortical gray nuclei except for the head of the caudate nucleus measured on the same MR scanner by the same observer. Bland-Altman analysis revealed that the points with susceptibility differences for all the subcortical gray nuclei except for substantia nigra located in the 95% CI of limits of agreement for the same MR scanner. The ICCs of the susceptibility value for the inter-scanner was 0.49 (0.08-0.75) for the head of the caudate nuleus, 0.80 (0.57-0.91) for the putamen, 0.77 (0.51-0.90) for the globus pallidus, 0.78 (0.54-0.91) for the thalamus, 0.80 (0.56-0.91) for the substantia nigra and 0.93 (0.83-0.97) for the red nucleus. The points with susceptibility difference (95.2%, 20/21) located in the 95% CI of limits of agreement for the putamen and the thalamus measured on two different MR scanners.
CONCLUSIONS
The intra-scanner reproducibility of QSM of the subcortical gray nuclei is superior to the inter-scanner reproducibility in healthy adults.
Adult
;
Brain/diagnostic imaging*
;
Gray Matter
;
Humans
;
Iron
;
Magnetic Resonance Imaging
;
Reproducibility of Results
;
Substantia Nigra/diagnostic imaging*